Danaher-IGI Beacon for CRISPR Cures Celebrates One-Year Anniversary

Danaher-IGI Beacon for CRISPR Cures Celebrates One-Year Anniversary

Berkeley—Nobel Laureate Jennifer Doudna, PhD, professor of biochemistry, biophysics, and structural biology at UC Berkeley, aspires for “CRISPR to become the standard of medical care for certain diseases” when asked for her dream for the technology in the next 5–10 years.  That dream has recently been challenged by a volatile climate, with public gene editing companies losing value in the past year, despite evidence of treatments showing efficac…